Park Place Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Park Place Capital's LLY Position: Q3 2026 in Review
Park Place Capital reduced its Eli Lilly (LLY) stake by 45% in Q3 2026, selling an estimated $431K and leaving 441 shares worth $510K. The position accounts for 0.19% of the portfolio, ranked #110.
Park Place Capital first reported a position in LLY in Q4 2022 and has held it in 16 quarters since. The position peaked at $2.17M in Q1 2024. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Park Place Capital held 441 shares of Eli Lilly worth $510K as of Q3 2026.
- Park Place Capital sold 365 Eli Lilly shares in Q3 2026, an estimated $431K.
- Eli Lilly made up 0.19% of Park Place Capital's portfolio in Q3 2026, its #110 holding.
- Park Place Capital first reported a position in Eli Lilly in Q4 2022 and has held it in 16 quarters since.
- Park Place Capital's Eli Lilly position peaked at $2.17M in Q1 2024.
- 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Park Place Capital's 13F filing for Q3 2026, filed 9 Nov 2026.